| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
4528 Stock Overview
Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
Rewards
Risk Analysis
No risks detected for 4528 from our risk checks.
Ono Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥3,399.00 |
| 52 Week High | JP¥3,990.00 |
| 52 Week Low | JP¥2,361.50 |
| Beta | 0.36 |
| 1 Month Change | -12.67% |
| 3 Month Change | -2.58% |
| 1 Year Change | 32.44% |
| 3 Year Change | 71.19% |
| 5 Year Change | 54.40% |
| Change since IPO | 176.34% |
Recent News & Updates
Shareholder Returns
| 4528 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | 1.0% | 3.9% | 2.5% |
| 1Y | 32.4% | 6.0% | 1.9% |
Return vs Industry: 4528 exceeded the JP Pharmaceuticals industry which returned 6% over the past year.
Return vs Market: 4528 exceeded the JP Market which returned 1.9% over the past year.
Price Volatility
| 4528 volatility | |
|---|---|
| 4528 Average Weekly Movement | 3.8% |
| Pharmaceuticals Industry Average Movement | 3.7% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 7.8% |
| 10% least volatile stocks in JP Market | 2.0% |
Stable Share Price: 4528 is not significantly more volatile than the rest of JP stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: 4528's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1717 | 3,687 | Gyo Sagara | https://www.ono-pharma.com |
Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER capsules for improvement of the symptoms in patients with pheochromocytoma; and MEKTOVI, VELEXBRU, and ADLUMIZ tablets, as well as BRAFTOVI capsules for malignant tumors. The company also provides GLACTIV and FORXIGA tablets for type 2 diabetes; FORXIGA tablets for the treatment of diabetes; ONOACT injections for tachyarrhythmia; OPALMON tablets to treat peripheral circulatory disorder; CORALAN for treatment of chronic heart failure; ORENCIA injections for rheumatoid arthritis; RIVASTACH patches for Alzheimer’s disease; ONGENTYS tablets for the treatment of Parkinson’s disease; PARSABIV, an intravenous injection for dialysis patients; STAYBLA tablets for overactive bladder; ONON capsules and dry syrups for bronchial asthma and allergic rhinitis; and JOYCLU intra-articular injection for the improvement of joint function, as well as RECALBON tablets for osteoporosis.
Ono Pharmaceutical Co., Ltd. Fundamentals Summary
| 4528 fundamental statistics | |
|---|---|
| Market Cap | JP¥1.66t |
| Earnings (TTM) | JP¥85.92b |
| Revenue (TTM) | JP¥380.72b |
19.3x
P/E Ratio4.4x
P/S RatioIs 4528 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4528 income statement (TTM) | |
|---|---|
| Revenue | JP¥380.72b |
| Cost of Revenue | JP¥97.65b |
| Gross Profit | JP¥283.07b |
| Other Expenses | JP¥197.15b |
| Earnings | JP¥85.92b |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 175.96 |
| Gross Margin | 74.35% |
| Net Profit Margin | 22.57% |
| Debt/Equity Ratio | 0% |
How did 4528 perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield32%
Payout RatioDoes 4528 pay a reliable dividends?
See 4528 dividend history and benchmarks| Ono Pharmaceutical dividend dates | |
|---|---|
| Ex Dividend Date | Sep 29 2022 |
| Dividend Pay Date | Dec 01 2022 |
| Days until Ex dividend | 42 days |
| Days until Dividend pay date | 105 days |
Does 4528 pay a reliable dividends?
See 4528 dividend history and benchmarks